Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
North South Ventures is a seed-stage venture capital fund based in key medical research hubs like Stanford/UCSF and the University of Toronto. The firm has invested in over 800 companies, leading to 23 unicorns and more than 100 FDA approvals. Their cumulative funding exceeds $4 billion.
This firm invests in early-stage biotech and healthtech companies that aim to enhance patient outcomes and streamline healthcare delivery. North South Ventures particularly seeks startups that provide innovative solutions to reduce administrative burdens within the healthcare sector.
Notable investments by North South Ventures include a non-hormonal male contraceptive pill, advanced genetic screening for embryos, AI-developed T-cell receptors for cancer treatment, and digital tools for women's health management.
Submit your pitch through their form at www.northsouthvc.com or email info@northsouthvc.com with your deck.
Yes, North South Ventures often leads investment rounds in the companies they back, particularly in the seed and pre-seed stages.
The firm is open to follow-on investments, especially in companies that demonstrate significant growth potential and align with their healthcare focus.
While specific fund sizes are not disclosed, North South Ventures has a cumulative funding of over $4 billion across its portfolio.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.